Sign in

CIK 0001396814

  • Large accelerated filer

Pacira BioSciences, Inc.

Sign in to watch
Ticker
PCRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
510619477
Phone
+1 650-242-8052
Business address
2000 SIERRA POINT PARKWAY, SUITE 900, BRISBANE, CA, 94005
Former names
Pacira Pharmaceuticals, Inc., PACIRA INC, Blue Acquisition Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$217,920
in 1 filing, $218K under 10b5-1 plans

Net −$217,920. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. RIKER LAUREN −$218K Senior Vice President, Finance sold 9% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-06-14 Riker Lauren Bullaro Senior Vice President, Finance Grant or award · Stock Option (Right to Buy) 10b5-1 +25,000 25,000
2023-06-14 Reinhart Charles A. III Chief Financial Officer Grant or award +9,000 42,626
2023-06-14 Reinhart Charles A. III Chief Financial Officer Grant or award · Stock Option (Right to Buy) +22,500 22,500
2023-06-14 PACE GARY W Director Grant or award +1,775 141,450
2023-06-14 PACE GARY W Director Grant or award · Stock Option (Right to Buy) +12,925 12,925
2023-06-14 Kronenfeld Mark A. Director Grant or award +1,775 19,672
2023-06-14 Kronenfeld Mark A. Director Grant or award · Stock Option (Right to Buy) +12,925 12,925
2023-06-14 HASTINGS PAUL J Director Grant or award +1,775 8,374
2023-06-14 HASTINGS PAUL J Director Grant or award · Stock Option (Right to Buy) +12,925 12,925
2023-06-14 GAUGLER DARYL Chief Operating Officer Grant or award +10,000 31,539
2023-06-14 GAUGLER DARYL Chief Operating Officer Grant or award · Stock Option (Right to Buy) +25,000 25,000
2023-06-14 Froimson Mark Director Grant or award +1,775 7,843
2023-06-14 Froimson Mark Director Grant or award · Stock Option (Right to Buy) +12,925 12,925
2023-06-14 CHRISTIE CHRISTOPHER Director Grant or award +1,775 5,261
2023-06-14 CHRISTIE CHRISTOPHER Director Grant or award · Stock Option (Right to Buy) +12,925 12,925
2023-06-14 Brege Laura Director Grant or award +1,775 11,322
2023-06-14 Brege Laura Director Grant or award · Stock Option (Right to Buy) +12,925 12,925
2023-06-08 Kronenfeld Mark A. Director Option exercise 10b5-1 +15,000 $29.90 $449K 32,897
2023-06-08 Kronenfeld Mark A. Director Sale 10b5-1 −15,000 $37.04 $556K 17,897
2023-06-08 Kronenfeld Mark A. Director Option exercise · Stock Option (Right to Buy) 10b5-1 −15,000 0

Page 10 of 23 · 450 trades